Neylan John F.

Track

Insider profile

Neylan John F.'s trades of Keryx Biopharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-16 2018-11-15
S Sale
27,758 -18.1%
302.45
US$3,691,756 		27,758 -18.1% 302.45 US$3,691,756
2018-10-30 2018-10-29
S Sale
88,196 +47.2%
33.99
US$2,834,638 		88,196 +47.2% 33.99 US$2,834,638
2018-08-16 2018-08-15
S Sale
50,623 -42.5%
274.22
US$4,164,336 		50,623 -42.5% 274.22 US$4,164,336
2018-07-31 2018-07-30
S Sale
1,282 -0.8%
3.86
US$4,949 		1,282 -0.8% 3.86 US$4,949
2018-05-16 2018-05-15
S Sale
1,158 -0.8%
5.69
US$6,589 		1,158 -0.8% 5.69 US$6,589
2018-05-01 2018-04-30
S Sale
1,311 -0.8%
4.67
US$6,122 		1,311 -0.8% 4.67 US$6,122
2018-02-16 2018-02-15
S Sale
5,652 -4.7%
4.81
US$27,186 		5,652 -4.7% 4.81 US$27,186
2018-01-24 2018-01-23
S Sale
1,322 -1.1%
4.92
US$6,504 		1,322 -1.1% 4.92 US$6,504
2017-10-31 2017-10-30
S Sale
1,405 -1.1%
6.03
US$8,472 		1,405 -1.1% 6.03 US$8,472
2017-10-24 2017-10-23
S Sale
1,179 -0.9%
6.53
US$7,699 		1,179 -0.9% 6.53 US$7,699
2017-08-01 2017-07-31
S Sale
1,445 -1.1%
7.14
US$10,317 		1,445 -1.1% 7.14 US$10,317
2017-07-25 2017-07-24
S Sale
1,214 -0.9%
7.27
US$8,826 		1,214 -0.9% 7.27 US$8,826
2017-05-03 2017-05-01
S Sale
1,441 -1.1%
5.97
US$8,603 		1,441 -1.1% 5.97 US$8,603
2017-04-26 2017-04-24
S Sale
1,209 -0.9%
5.73
US$6,928 		1,209 -0.9% 5.73 US$6,928
2017-01-25 2017-01-23
S Sale
1,428 -1.6%
5.39
US$7,697 		1,428 -1.6% 5.39 US$7,697
2016-10-25 2016-10-24
S Sale
1,211 -1.3%
4.72
US$5,716 		1,211 -1.3% 4.72 US$5,716